Straightforward single-cell profiling at your fingertips

Scipio has been riding its initial success and significantly expanded since its inception, and a new website was required to reflect such progress! You can now find more details about the Scipio technology and the team members, but its most important feature is the launch of the new Benchtop Single-Cell blog which will focus on, well, single-cell science.

A total of €6.0m has been obtained from an international syndicate led by M Ventures (Amsterdam, The Netherlands), the corporate venture capital arm of Merck. The initial shareholders Seventure Partners' Quadrivum I (Paris, France) and High-Tech Gründerfonds (Bonn, Germany) participated in the capital increase, alongside additional investors Financière Arbevel (Paris, France) and Investiere Venture Capital (Zürich, Switzerland).